Litcius/Paper detail

New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine

Yasser Aladdin, Bader Shirah

2021Journal of Neuroimmunology40 citationsDOIOpen Access PDF

Topics & Concepts

VaccinationMedicineStatus epilepticusReactogenicityRefractory (planetary science)PlasmapheresisEpilepsyFulminantPandemicPediatricsIntensive care medicineImmunologyCoronavirus disease 2019 (COVID-19)ImmunizationDiseaseImmune systemInternal medicineAntibodyBiologyPsychiatryInfectious disease (medical specialty)AstrobiologySARS-CoV-2 and COVID-19 ResearchInfectious Encephalopathies and EncephalitisLong-Term Effects of COVID-19
New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine | Litcius